A detailed history of Militia Capital Partners, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Militia Capital Partners, LP holds 35,000 shares of QURE stock, worth $1.05 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
35,000
Previous 22,200 57.66%
Holding current value
$1.05 Million
Previous $309 Million 560.15%
% of portfolio
0.96%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$13.28 - $59.4 $169,984 - $760,320
12,800 Added 57.66%
35,000 $2.04 Billion
Q2 2025

Aug 14, 2025

BUY
$8.34 - $17.27 $185,148 - $383,394
22,200 New
22,200 $309 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $1.4B
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Militia Capital Partners, LP Portfolio

Follow Militia Capital Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Militia Capital Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Militia Capital Partners, LP with notifications on news.